BOSUTINIB

BOSUTINIB was reported 8981 times

BOSUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TYROSINE KINASE MUTATION 4 0.1600
1 MICROVASCULAR CRANIAL NERVE PALSY 3 0.1364
2 CYTOGENETIC ANALYSIS ABNORMAL 110 0.1050
3 PHILADELPHIA CHROMOSOME POSITIVE 67 0.0917
4 CLONAL EVOLUTION 7 0.0673
5 AORTIC ELONGATION 3 0.0517
6 LYMPHANGIECTASIA 3 0.0429
7 CHRONIC MYELOID LEUKAEMIA RECURRENT 22 0.0402
8 ATYPICAL FIBROXANTHOMA 3 0.0400
9 BONE MARROW OEDEMA SYNDROME 3 0.0400
10 SEVERE CUTANEOUS ADVERSE REACTION 9 0.0377
11 GRAFT VERSUS HOST DISEASE IN EYE 8 0.0346
12 CHRONIC MYELOID LEUKAEMIA 148 0.0320
13 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 38 0.0308
14 DRUG RESISTANCE MUTATION 5 0.0281
15 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 12 0.0269
16 SUBCLAVIAN ARTERY STENOSIS 4 0.0256
17 EPIPLOIC APPENDAGITIS 3 0.0234
18 CHYLOTHORAX 15 0.0208
19 GENE MUTATION IDENTIFICATION TEST POSITIVE 8 0.0190
20 BLAST CELL CRISIS 6 0.0181
21 MYOPATHY TOXIC 11 0.0178
22 VENOUS STENOSIS 4 0.0159
23 HYDROTHORAX 13 0.0157
24 PERIPHERAL ARTERY STENOSIS 7 0.0146
25 EHLERS-DANLOS SYNDROME 6 0.0129
26 CEREBRAL MICROANGIOPATHY 3 0.0126
27 SECOND PRIMARY MALIGNANCY 103 0.0124
28 WRONG STRENGTH 4 0.0121
29 LIVER FUNCTION TEST DECREASED 4 0.0111
30 DRY GANGRENE 7 0.0110
31 BLOOD PH INCREASED 6 0.0108
32 NEOPLASM PROGRESSION 373 0.0107
33 ACQUIRED GENE MUTATION 13 0.0099
34 GRANULOCYTE COUNT INCREASED 4 0.0099
35 COLD-STIMULUS HEADACHE 3 0.0094
36 FULL BLOOD COUNT INCREASED 10 0.0084
37 MYOSCLEROSIS 3 0.0081
38 INFECTIOUS COLITIS 4 0.0076
39 PLEURAL EFFUSION 458 0.0075
40 PANCREAS INFECTION 3 0.0075
41 PLEUROPERICARDITIS 3 0.0073
42 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 3 0.0071
43 PERICARDITIS CONSTRICTIVE 3 0.0071
44 TOXIC LEUKOENCEPHALOPATHY 5 0.0069
45 ACUTE LYMPHOCYTIC LEUKAEMIA 19 0.0067
46 CREATININE RENAL CLEARANCE INCREASED 5 0.0067
47 GENE MUTATION 13 0.0066
48 GASTROINTESTINAL STOMA OUTPUT INCREASED 3 0.0064
49 ARTERITIS 4 0.0063
50 INTERMITTENT CLAUDICATION 10 0.0063
51 CAPILLARY LEAK SYNDROME 13 0.0063
52 CYTOGENETIC ABNORMALITY 7 0.0062
53 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 25 0.0061
54 MYELOPROLIFERATIVE NEOPLASM 4 0.0060
55 CYTOPENIA 73 0.0060
56 MARROW HYPERPLASIA 4 0.0059
57 DRUG RESISTANCE 149 0.0058
58 BONE MARROW OEDEMA 6 0.0058
59 NEOPLASM RECURRENCE 18 0.0053
60 ASPIRATION PLEURAL CAVITY 4 0.0052
61 LYMPHOCYTE MORPHOLOGY ABNORMAL 3 0.0052
62 AORTIC DISORDER 4 0.0051
63 MEAN PLATELET VOLUME INCREASED 3 0.0050
64 CAROTID ARTERIOSCLEROSIS 5 0.0048
65 SPLEEN DISORDER 8 0.0047
66 ARTERIAL DISORDER 9 0.0047
67 CHRONIC MYELOMONOCYTIC LEUKAEMIA 3 0.0045
68 EMERGENCY CARE EXAMINATION 3 0.0044
69 CUTANEOUS SYMPTOM 3 0.0044
70 AMYLASE INCREASED 16 0.0043
71 PULMONARY ARTERIAL PRESSURE INCREASED 7 0.0043
72 MONOCYTE PERCENTAGE INCREASED 3 0.0042
73 LEUKAEMIA RECURRENT 7 0.0041
74 PERICARDIAL EFFUSION 95 0.0041
75 HAEMATOTOXICITY 38 0.0040
76 CREATINE KINASE INCREASED 3 0.0039
77 ESSENTIAL HYPERTENSION 7 0.0038
78 BLAST CELL COUNT INCREASED 4 0.0038
79 HAEMORRHAGIC DISORDER 4 0.0037
80 POLYCYTHAEMIA VERA 3 0.0037
81 GLOMERULAR FILTRATION RATE INCREASED 3 0.0036
82 RENAL ARTERY STENOSIS 5 0.0036
83 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 6 0.0036
84 PERIPHERAL ARTERY OCCLUSION 5 0.0036
85 TUMOUR MARKER INCREASED 17 0.0035
86 GASTROINTESTINAL TOXICITY 17 0.0035
87 AUTOIMMUNE HAEMOLYTIC ANAEMIA 12 0.0035
88 LOSS OF THERAPEUTIC RESPONSE 11 0.0034
89 CAROTID ARTERY STENOSIS 12 0.0034
90 PLATELET COUNT INCREASED 44 0.0034
91 IRON DEFICIENCY 15 0.0033
92 DRUG INTOLERANCE 318 0.0033
93 PULMONARY HYPERTENSION 68 0.0033
94 DIARRHOEA 2078 0.0032
95 LIVER FUNCTION TEST INCREASED 69 0.0032
96 NEUTROPENIC INFECTION 3 0.0031
97 PERIPHERAL VASCULAR DISORDER 16 0.0031
98 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 8 0.0031
99 PULMONARY OEDEMA 138 0.0031
100 PLATELET COUNT ABNORMAL 18 0.0030
101 FLUID RETENTION 150 0.0029
102 EFFUSION 4 0.0029
103 LIVEDO RETICULARIS 6 0.0029
104 LIPASE INCREASED 22 0.0029
105 CORONARY ARTERY STENOSIS 14 0.0028
106 BLOOD URIC ACID INCREASED 16 0.0028
107 MUTISM 4 0.0028
108 GASTROINTESTINAL TRACT IRRITATION 3 0.0027
109 PANCREATIC ENZYMES INCREASED 4 0.0027
110 WHITE BLOOD CELL COUNT INCREASED 103 0.0027
111 THYROIDITIS 8 0.0027
112 WHITE BLOOD CELL COUNT ABNORMAL 17 0.0027
113 BONE MARROW DISORDER 8 0.0026
114 PULMONARY ARTERIAL HYPERTENSION 38 0.0026
115 PALMAR ERYTHEMA 3 0.0026
116 DAYDREAMING 4 0.0026
117 NECK SURGERY 6 0.0026
118 EARLY SATIETY 5 0.0026
119 PERIORBITAL OEDEMA 13 0.0025
120 BLOOD CREATINE INCREASED 11 0.0025
121 MONOCYTE COUNT INCREASED 9 0.0025
122 SKIN TOXICITY 14 0.0025
123 ARTERIOSCLEROSIS 23 0.0024
124 PLEURISY 14 0.0024
125 CONJUNCTIVAL HAEMORRHAGE 9 0.0024
126 MUSCLE DISORDER 19 0.0023
127 ERYTHEMA NODOSUM 8 0.0023
128 BLOOD BLISTER 7 0.0022
129 BLOOD CREATININE DECREASED 7 0.0022
130 RENAL FUNCTION TEST ABNORMAL 10 0.0022
131 CARDIOVERSION 3 0.0021
132 LABORATORY TEST ABNORMAL 63 0.0021
133 AUDITORY DISORDER 3 0.0021
134 PANCREATITIS CHRONIC 5 0.0021
135 FULL BLOOD COUNT ABNORMAL 22 0.0021
136 ARTERIAL THROMBOSIS 4 0.0021
137 TRANSAMINASES INCREASED 46 0.0021
138 RETINAL TEAR 5 0.0020
139 HEPATOTOXICITY 45 0.0020
140 STEM CELL TRANSPLANT 5 0.0020
141 ARTERIOSPASM CORONARY 8 0.0020
142 BLOOD TEST ABNORMAL 28 0.0020
143 BONE PAIN 116 0.0020
144 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
145 ONYCHOLYSIS 3 0.0019
146 THROMBOCYTOSIS 7 0.0019
147 ILLNESS 193 0.0019
148 WHITE BLOOD CELL DISORDER 5 0.0019
149 HYPOACUSIS 80 0.0019
150 BLOOD COUNT ABNORMAL 28 0.0018
151 HEPATIC ENZYME ABNORMAL 9 0.0018
152 DIABETIC RETINOPATHY 6 0.0018
153 ACUTE GRAFT VERSUS HOST DISEASE 8 0.0017
154 MILIARIA 3 0.0017
155 FUNCTIONAL GASTROINTESTINAL DISORDER 6 0.0017
156 GASTRITIS EROSIVE 8 0.0017
157 HYPERURICAEMIA 7 0.0017
158 SPINAL STENOSIS 7 0.0017
159 RENAL DISORDER 79 0.0017
160 NEPHROPATHY TOXIC 19 0.0017
161 HEPATIC ENZYME INCREASED 114 0.0017
162 WEIGHT ABNORMAL 4 0.0017
163 RASH VESICULAR 8 0.0017
164 HEPATIC CYTOLYSIS 21 0.0016
165 HYPERVOLAEMIA 8 0.0016
166 CATHETER PLACEMENT 3 0.0016
167 GENERALISED OEDEMA 20 0.0016
168 LYMPH NODE PAIN 3 0.0016
169 LEUKAEMIA 15 0.0016
170 BONE MARROW TRANSPLANT 3 0.0016
171 AORTIC ARTERIOSCLEROSIS 4 0.0016
172 PAPILLOEDEMA 7 0.0015
173 LEUKOCYTOSIS 28 0.0015
174 ABDOMINAL WALL HAEMATOMA 3 0.0015
175 EPIGASTRIC DISCOMFORT 6 0.0015
176 LUNG OPACITY 4 0.0015
177 NEAR DEATH EXPERIENCE 5 0.0015
178 FAECES SOFT 11 0.0015
179 OEDEMA 82 0.0015
180 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
181 POTENTIATING DRUG INTERACTION 5 0.0015
182 SHOULDER ARTHROPLASTY 4 0.0015
183 CARDIAC TAMPONADE 7 0.0015
184 CHANGE OF BOWEL HABIT 3 0.0015
185 BRONCHIOLITIS 5 0.0014
186 EAR SWELLING 3 0.0014
187 GASTROINTESTINAL SOUNDS ABNORMAL 7 0.0014
188 CARDIAC VALVE DISEASE 8 0.0014
189 LIVER DISORDER 62 0.0014
190 VOMITING PROJECTILE 4 0.0014
191 GASTRIC BYPASS 3 0.0014
192 BLOOD DISORDER 11 0.0014
193 HYPERTRIGLYCERIDAEMIA 8 0.0014
194 IMMUNE SYSTEM DISORDER 18 0.0014
195 GASTROINTESTINAL DISORDER 122 0.0014
196 GOUT 24 0.0013
197 ALANINE AMINOTRANSFERASE INCREASED 81 0.0013
198 FACE INJURY 5 0.0013
199 KERATITIS 4 0.0013
200 LICHENOID KERATOSIS 3 0.0013
201 CARDIAC FAILURE 105 0.0013
202 PIGMENTATION DISORDER 8 0.0013
203 NAUSEA 1020 0.0013
204 RENAL IMPAIRMENT 108 0.0013
205 SPLENOMEGALY 15 0.0013
206 CARDIAC OPERATION 11 0.0013
207 PULMONARY HAEMORRHAGE 10 0.0013
208 FAECALOMA 7 0.0013
209 ABDOMINAL DISCOMFORT 214 0.0013
210 PHOTOSENSITIVITY REACTION 21 0.0013
211 EOSINOPHILIC PNEUMONIA 4 0.0013
212 PANCREATITIS 67 0.0013
213 RED BLOOD CELL COUNT DECREASED 36 0.0013
214 PNEUMONIA VIRAL 4 0.0013
215 ANGIOPATHY 7 0.0012
216 CARDIAC FLUTTER 8 0.0012
217 FLUID OVERLOAD 18 0.0012
218 BRONCHITIS CHRONIC 3 0.0012
219 LYMPHOCYTE COUNT INCREASED 4 0.0012
220 PANCREATIC DISORDER 6 0.0012
221 PRODUCT PRESCRIBING ERROR 29 0.0012
222 VENTRICULAR TACHYCARDIA 20 0.0012
223 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 4 0.0012
224 CARDIAC FAILURE CONGESTIVE 97 0.0012
225 ABDOMINAL PAIN UPPER 247 0.0012
226 IRON DEFICIENCY ANAEMIA 11 0.0012
227 PLATELET DISORDER 3 0.0012
228 ASPARTATE AMINOTRANSFERASE INCREASED 63 0.0012
229 PANCYTOPENIA 66 0.0012
230 APPENDICITIS PERFORATED 3 0.0012
231 ILEOSTOMY 3 0.0012
232 CANCER PAIN 3 0.0012
233 HEPATIC PAIN 5 0.0012
234 INTERVERTEBRAL DISC DISORDER 5 0.0012
235 LIVER FUNCTION TEST ABNORMAL 34 0.0012
236 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
237 GASTROENTERITIS 17 0.0012
238 LEFT VENTRICULAR FAILURE 4 0.0012
239 VOMITING 544 0.0012
240 HYPERTRANSAMINASAEMIA 8 0.0011
241 BRAIN FOG 18 0.0011
242 ABDOMINAL PAIN 267 0.0011
243 IMMOBILE 5 0.0011
244 EAR PRURITUS 4 0.0011
245 SKIN DISORDER 38 0.0011
246 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
247 CARDIOMEGALY 14 0.0011
248 BLOOD CREATININE INCREASED 74 0.0011
249 ULCER 18 0.0011
250 PULMONARY TOXICITY 8 0.0011
251 RASH 492 0.0011
252 EATING DISORDER 24 0.0011
253 GLOSSITIS 4 0.0011
254 BLOOD POTASSIUM ABNORMAL 3 0.0011
255 THERAPY CHANGE 11 0.0011
256 PLATELET COUNT DECREASED 119 0.0011
257 SUSPECTED OFF LABEL USE 5 0.0011
258 CARDIAC DISORDER 103 0.0011
259 TOXIC SKIN ERUPTION 11 0.0011
260 IMMUNE THROMBOCYTOPENIA 5 0.0011
261 EAR DISORDER 5 0.0011
262 HAEMOGLOBIN DECREASED 112 0.0011
263 HAEMOGLOBIN ABNORMAL 7 0.0011
264 FEEDING DISORDER 22 0.0011
265 TASTE DISORDER 22 0.0011
266 GASTRIC ULCER HAEMORRHAGE 6 0.0011
267 DRUG TOLERANCE DECREASED 3 0.0011
268 SCIATICA 17 0.0011
269 OXYGEN SATURATION ABNORMAL 3 0.0011
270 OESOPHAGEAL STENOSIS 3 0.0011
271 PETECHIAE 11 0.0011
272 BOWEL MOVEMENT IRREGULARITY 8 0.0010
273 FULL BLOOD COUNT DECREASED 21 0.0010
274 ATRIAL FIBRILLATION 101 0.0010
275 MYELODYSPLASTIC SYNDROME 15 0.0010
276 EYELID OEDEMA 12 0.0010
277 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
278 THERAPY NON-RESPONDER 46 0.0010
279 THERAPY INTERRUPTED 73 0.0010
280 GROWTH RETARDATION 3 0.0010
281 VULVOVAGINAL MYCOTIC INFECTION 4 0.0010
282 RASH PRURITIC 55 0.0010
283 BLOOD IRON DECREASED 12 0.0010
284 PRODUCT DISPENSING ERROR 22 0.0010
285 CREPITATIONS 3 0.0010
286 MYOSITIS 9 0.0010
287 RIGHT VENTRICULAR FAILURE 7 0.0010
288 DYSPEPSIA 98 0.0010
289 GANGRENE 6 0.0010
290 CEREBROVASCULAR DISORDER 3 0.0010
291 THROMBOCYTOPENIA 111 0.0010
292 MYELOFIBROSIS 3 0.0010
293 HEPATOCELLULAR INJURY 14 0.0010
294 DISEASE PROGRESSION 116 0.0010
295 DIASTOLIC DYSFUNCTION 3 0.0010
296 CEREBRAL ISCHAEMIA 5 0.0010
297 FLATULENCE 55 0.0010
298 DERMATITIS BULLOUS 7 0.0010
299 INTERNAL HAEMORRHAGE 11 0.0010
300 HAEMATOCRIT DECREASED 19 0.0010
301 GASTROOESOPHAGEAL REFLUX DISEASE 77 0.0010
302 DYSPNOEA EXERTIONAL 36 0.0010
303 CONSTIPATION 207 0.0009
304 HEPATITIS B REACTIVATION 3 0.0009
305 CARDIAC FAILURE CHRONIC 4 0.0009
306 DEHYDRATION 125 0.0009
307 ANAL FISTULA 5 0.0009
308 PRODUCT DISPENSING ISSUE 4 0.0009
309 THERAPY CESSATION 48 0.0009
310 FATIGUE 728 0.0009
311 BONE MARROW FAILURE 19 0.0009
312 HYPERCHOLESTEROLAEMIA 9 0.0009
313 ATELECTASIS 9 0.0009
314 HYPERLIPIDAEMIA 11 0.0009
315 MELANOCYTIC NAEVUS 4 0.0009
316 SUBDURAL HAEMATOMA 13 0.0009
317 PROSTATIC DISORDER 5 0.0009
318 HYPERKERATOSIS 5 0.0009
319 LUNG INFILTRATION 8 0.0009
320 APPETITE DISORDER 6 0.0009
321 BRONCHOPULMONARY ASPERGILLOSIS 7 0.0009
322 NECROSIS 5 0.0009
323 PERICARDITIS 15 0.0009
324 BLOOD BILIRUBIN INCREASED 24 0.0009
325 ULCER HAEMORRHAGE 6 0.0009
326 FURUNCLE 7 0.0009
327 CHOLECYSTITIS ACUTE 5 0.0009
328 HEPATIC FIBROSIS 3 0.0009
329 EYE OPERATION 4 0.0009
330 NERVE COMPRESSION 8 0.0009
331 SYNOVIAL CYST 4 0.0009
332 LARGE INTESTINE POLYP 6 0.0009
333 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
334 ARTHRITIS INFECTIVE 4 0.0009
335 BLOOD POTASSIUM INCREASED 14 0.0009
336 AORTIC STENOSIS 3 0.0009
337 DECREASED APPETITE 200 0.0009
338 WEIGHT FLUCTUATION 9 0.0009
339 DEMENTIA 24 0.0009
340 RASH MACULAR 30 0.0009
341 ERYTHEMA MULTIFORME 8 0.0009
342 EOSINOPHILIA 15 0.0009
343 LIVER INJURY 21 0.0009
344 POLYURIA 7 0.0009
345 POOR QUALITY PRODUCT ADMINISTERED 9 0.0009
346 RASH GENERALISED 22 0.0008
347 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
348 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
349 ACUTE CORONARY SYNDROME 7 0.0008
350 GASTRIC DISORDER 29 0.0008
351 GASTRIC ULCER 16 0.0008
352 INTENTIONAL DOSE OMISSION 24 0.0008
353 EOSINOPHIL COUNT INCREASED 7 0.0008
354 SKIN LESION 23 0.0008
355 LIMB OPERATION 4 0.0008
356 HEPATIC FUNCTION ABNORMAL 31 0.0008
357 PRODUCT PRESCRIBING ISSUE 18 0.0008
358 HEPATOMEGALY 8 0.0008
359 INTENTIONAL PRODUCT MISUSE 71 0.0008
360 PYELONEPHRITIS 7 0.0008
361 ANAEMIA 154 0.0008
362 ORGANISING PNEUMONIA 4 0.0008
363 CARDIAC DYSFUNCTION 3 0.0008
364 HYPERACUSIS 3 0.0008
365 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7 0.0008
366 ANGINA PECTORIS 23 0.0008
367 URINE OUTPUT DECREASED 7 0.0008
368 MYALGIA 136 0.0008
369 GASTRITIS 21 0.0008
370 MYOCARDIAL INFARCTION 139 0.0008
371 AUTOIMMUNE THYROIDITIS 3 0.0008
372 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
373 KLEBSIELLA INFECTION 4 0.0008
374 TOE AMPUTATION 4 0.0008
375 CARDIOTOXICITY 7 0.0008
376 TREATMENT FAILURE 65 0.0008
377 WEIGHT DECREASED 219 0.0008
378 RENAL FAILURE 104 0.0008
379 PROCTALGIA 5 0.0008
380 PRODUCT DOSE OMISSION IN ERROR 22 0.0008
381 ERUCTATION 15 0.0008
382 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
383 CONCUSSION 6 0.0008
384 WHITE BLOOD CELL COUNT DECREASED 84 0.0008
385 VENTRICULAR EXTRASYSTOLES 8 0.0008
386 CANDIDA INFECTION 13 0.0008
387 HAEMORRHOIDS 15 0.0008
388 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
389 SENSITIVITY TO WEATHER CHANGE 4 0.0008
390 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
391 CARDIAC FAILURE ACUTE 5 0.0007
392 EYE HAEMORRHAGE 10 0.0007
393 MENINGITIS 5 0.0007
394 STENT PLACEMENT 6 0.0007
395 FRUSTRATION TOLERANCE DECREASED 6 0.0007
396 COLITIS ISCHAEMIC 5 0.0007
397 BLINDNESS 30 0.0007
398 PERIPHERAL ISCHAEMIA 3 0.0007
399 HEAD DISCOMFORT 13 0.0007
400 HYPERAESTHESIA 6 0.0007
401 NEPHROTIC SYNDROME 5 0.0007
402 GALLBLADDER DISORDER 13 0.0007
403 GASTROINTESTINAL PAIN 8 0.0007
404 BLOOD UREA INCREASED 12 0.0007
405 ACUTE PULMONARY OEDEMA 4 0.0007
406 ACUTE MYOCARDIAL INFARCTION 21 0.0007
407 CARDIOVASCULAR DISORDER 18 0.0007
408 DUODENAL ULCER 5 0.0007
409 CHEST PAIN 131 0.0007
410 DIALYSIS 10 0.0007
411 MYOCARDIAL ISCHAEMIA 8 0.0007
412 RETINAL HAEMORRHAGE 5 0.0007
413 SCAB 8 0.0007
414 ANURIA 6 0.0007
415 CEREBRAL INFARCTION 17 0.0007
416 HERPES VIRUS INFECTION 4 0.0007
417 HORDEOLUM 3 0.0007
418 ENTEROCOLITIS 4 0.0007
419 GAIT INABILITY 23 0.0007
420 DIVERTICULUM INTESTINAL 3 0.0007
421 NEUTROPHIL COUNT INCREASED 7 0.0007
422 MALIGNANT NEOPLASM PROGRESSION 70 0.0007
423 ORAL DISORDER 5 0.0007
424 TUMOUR LYSIS SYNDROME 6 0.0007
425 INTERSTITIAL LUNG DISEASE 33 0.0007
426 AGEUSIA 17 0.0007
427 MALAISE 298 0.0007
428 THERAPEUTIC RESPONSE DECREASED 41 0.0007
429 PERIPHERAL SWELLING 104 0.0007
430 CARDIAC PACEMAKER INSERTION 4 0.0007
431 GASTROINTESTINAL INFECTION 6 0.0007
432 RASH PAPULAR 15 0.0007
433 SYMPTOM RECURRENCE 4 0.0007
434 TRANSFUSION 7 0.0007
435 ELECTROCARDIOGRAM QT PROLONGED 24 0.0007
436 ASTHENIA 250 0.0007
437 BACK PAIN 154 0.0007
438 PAROSMIA 5 0.0007
439 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
440 ABDOMINAL DISTENSION 69 0.0007
441 LIP SWELLING 22 0.0007
442 RENAL PAIN 7 0.0007
443 NOCTURIA 8 0.0007
444 PNEUMONIA BACTERIAL 6 0.0007
445 ISCHAEMIA 3 0.0007
446 DEAFNESS 17 0.0006
447 THYROID DISORDER 10 0.0006
448 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
449 MEMORY IMPAIRMENT 89 0.0006
450 MUSCULOSKELETAL CHEST PAIN 10 0.0006
451 APHONIA 9 0.0006
452 NECK PAIN 36 0.0006
453 COVID-19 113 0.0006
454 BACK INJURY 7 0.0006
455 DYSPNOEA 364 0.0006
456 MUSCLE SPASMS 118 0.0006
457 CEREBRAL HAEMORRHAGE 23 0.0006
458 DRUG-INDUCED LIVER INJURY 20 0.0006
459 SWELLING OF EYELID 4 0.0006
460 PNEUMONIA 206 0.0006
461 COLITIS MICROSCOPIC 3 0.0006
462 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
463 RASH MACULO-PAPULAR 14 0.0006
464 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
465 OBESITY 10 0.0006
466 HYPOVOLAEMIC SHOCK 3 0.0006
467 PULMONARY FIBROSIS 12 0.0006
468 ENTERITIS 4 0.0006
469 CHOLESTASIS 12 0.0006
470 DEATH 538 0.0006
471 APHAGIA 3 0.0006
472 LYMPHOCYTE COUNT DECREASED 11 0.0006
473 EYE SWELLING 23 0.0006
474 NEURALGIA 15 0.0006
475 ARTHRALGIA 256 0.0006
476 ANGINA UNSTABLE 4 0.0006
477 CEREBROVASCULAR ACCIDENT 104 0.0006
478 ASCITES 18 0.0006
479 GASTRIC HAEMORRHAGE 7 0.0006
480 IRRITABLE BOWEL SYNDROME 13 0.0006
481 CORONAVIRUS INFECTION 4 0.0006
482 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
483 BLOOD PRESSURE ABNORMAL 12 0.0006
484 POLLAKIURIA 25 0.0006
485 SWELLING 56 0.0006
486 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
487 FACE OEDEMA 10 0.0006
488 HIP FRACTURE 19 0.0006
489 TOOTH ABSCESS 6 0.0006
490 HEPATITIS 15 0.0006
491 EAR DISCOMFORT 6 0.0006
492 CACHEXIA 3 0.0006
493 SKIN HYPERPIGMENTATION 5 0.0006
494 SKIN ULCER 15 0.0006
495 BLOOD URINE PRESENT 11 0.0006
496 AUTOIMMUNE HEPATITIS 4 0.0006
497 SPINAL OPERATION 7 0.0006
498 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
499 HYPERTENSION 120 0.0006
500 PYREXIA 196 0.0006
501 SKIN DISCOLOURATION 26 0.0006
502 RASH ERYTHEMATOUS 27 0.0006
503 DRUG ERUPTION 10 0.0006
504 THERMAL BURN 4 0.0006
505 DRUG INTERACTION 89 0.0006
506 ISCHAEMIC STROKE 10 0.0006
507 FOOD POISONING 3 0.0006
508 ANAL FISSURE 3 0.0006
509 OVERWEIGHT 3 0.0006
510 JAUNDICE 15 0.0006
511 DERMATITIS ALLERGIC 7 0.0006
512 GRAFT VERSUS HOST DISEASE 4 0.0006
513 MUSCLE TIGHTNESS 9 0.0006
514 HIP SURGERY 3 0.0006
515 GASTROENTERITIS VIRAL 10 0.0006
516 FAECES DISCOLOURED 12 0.0006
517 TONGUE DISORDER 4 0.0006
518 DIABETES MELLITUS 42 0.0006
519 ARRHYTHMIA 26 0.0005
520 HYPERKALAEMIA 19 0.0005
521 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 26 0.0005
522 CEREBRAL DISORDER 4 0.0005
523 HEADACHE 339 0.0005
524 SUNBURN 4 0.0005
525 BACTERIAL INFECTION 10 0.0005
526 ORAL PAIN 12 0.0005
527 NEPHROPATHY 5 0.0005
528 DIARRHOEA HAEMORRHAGIC 5 0.0005
529 BLOOD CALCIUM DECREASED 6 0.0005
530 OEDEMA PERIPHERAL 65 0.0005
531 HEPATIC CIRRHOSIS 10 0.0005
532 EYE INFECTION 6 0.0005
533 COUGH 149 0.0005
534 LUNG DISORDER 26 0.0005
535 ACUTE KIDNEY INJURY 81 0.0005
536 CORONARY ARTERY DISEASE 16 0.0005
537 PERONEAL NERVE PALSY 3 0.0005
538 FOOT FRACTURE 10 0.0005
539 TROPONIN INCREASED 4 0.0005
540 NEUROPATHY PERIPHERAL 50 0.0005
541 NEUROLOGICAL SYMPTOM 3 0.0005
542 AMNESIA 34 0.0005
543 CORONARY ARTERY BYPASS 3 0.0005
544 MOUTH SWELLING 3 0.0005
545 HERNIA 10 0.0005
546 PRESCRIBED OVERDOSE 10 0.0005
547 ELECTROLYTE IMBALANCE 6 0.0005
548 CELLULITIS 26 0.0005
549 RETCHING 11 0.0005
550 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
551 EJECTION FRACTION DECREASED 8 0.0005
552 DYSPHONIA 30 0.0005
553 VITAMIN D DEFICIENCY 5 0.0005
554 PHARYNGEAL SWELLING 5 0.0005
555 WEIGHT INCREASED 114 0.0005
556 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
557 DIVERTICULITIS 14 0.0005
558 ODYNOPHAGIA 3 0.0005
559 GINGIVAL PAIN 4 0.0005
560 NEPHROLITHIASIS 23 0.0005
561 COLITIS 19 0.0005
562 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
563 OSTEOMYELITIS 9 0.0005
564 INGUINAL HERNIA 3 0.0005
565 BACK DISORDER 8 0.0005
566 SUBARACHNOID HAEMORRHAGE 5 0.0005
567 MENISCUS INJURY 3 0.0005
568 CHROMATURIA 11 0.0005
569 EYE DISORDER 16 0.0005
570 HYPERCALCAEMIA 6 0.0005
571 PAIN IN EXTREMITY 143 0.0005
572 LIMB DISCOMFORT 15 0.0005
573 ALOPECIA 95 0.0005
574 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
575 THINKING ABNORMAL 9 0.0005
576 HEAD INJURY 15 0.0005
577 MUSCULOSKELETAL DISORDER 9 0.0005
578 SUDDEN DEATH 5 0.0005
579 SLEEP APNOEA SYNDROME 9 0.0005
580 COLON CANCER 7 0.0005
581 BODY HEIGHT DECREASED 5 0.0005
582 BLOOD MAGNESIUM DECREASED 4 0.0005
583 CARDIAC MURMUR 4 0.0005
584 PHARYNGITIS STREPTOCOCCAL 5 0.0005
585 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
586 BRONCHITIS 34 0.0005
587 MUSCULOSKELETAL PAIN 24 0.0005
588 SPEECH DISORDER 24 0.0005
589 PRURITUS 176 0.0005
590 CHOLELITHIASIS 15 0.0005
591 HYPOGAMMAGLOBULINAEMIA 3 0.0005
592 INFECTION 66 0.0005
593 GROIN PAIN 4 0.0005
594 DYSGRAPHIA 3 0.0005
595 MELAENA 10 0.0005
596 ANKLE FRACTURE 7 0.0005
597 VENTRICULAR FIBRILLATION 5 0.0004
598 TOOTH DISORDER 10 0.0004
599 URTICARIA 75 0.0004
600 PRODUCT ADMINISTRATION ERROR 9 0.0004
601 DYSSTASIA 13 0.0004
602 PANCREATITIS ACUTE 10 0.0004
603 OXYGEN SATURATION DECREASED 25 0.0004
604 PRODUCT DOSE OMISSION 29 0.0004
605 DYSGEUSIA 33 0.0004
606 TOOTHACHE 8 0.0004
607 BODY TEMPERATURE INCREASED 9 0.0004
608 ABSCESS 7 0.0004
609 HYPOTHYROIDISM 14 0.0004
610 JOINT EFFUSION 3 0.0004
611 DYSURIA 16 0.0004
612 DRY SKIN 58 0.0004
613 NIGHT SWEATS 14 0.0004
614 HAIR GROWTH ABNORMAL 3 0.0004
615 FEELING COLD 12 0.0004
616 HYPOPHAGIA 11 0.0004
617 HAEMOPTYSIS 12 0.0004
618 EXTRASYSTOLES 3 0.0004
619 ANGIOEDEMA 19 0.0004
620 DEFAECATION URGENCY 3 0.0004
621 BLISTER 24 0.0004
622 FLANK PAIN 4 0.0004
623 SKIN REACTION 6 0.0004
624 HOSPITALISATION 65 0.0004
625 FEELING ABNORMAL 101 0.0004
626 INFLUENZA 47 0.0004
627 CHOLECYSTITIS 5 0.0004
628 BLOOD PRESSURE FLUCTUATION 10 0.0004
629 SKIN EXFOLIATION 35 0.0004
630 MENTAL IMPAIRMENT 10 0.0004
631 NEUTROPENIA 56 0.0004
632 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
633 RESPIRATORY FAILURE 30 0.0004
634 DYSPHAGIA 39 0.0004
635 PALPITATIONS 48 0.0004
636 GAIT DISTURBANCE 78 0.0004
637 NASOPHARYNGITIS 75 0.0004
638 COGNITIVE DISORDER 19 0.0004
639 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
640 STEVENS-JOHNSON SYNDROME 9 0.0004
641 PNEUMONITIS 11 0.0004
642 MOOD ALTERED 11 0.0004
643 PHARYNGITIS 5 0.0004
644 CYST 5 0.0004
645 BLADDER DISORDER 4 0.0004
646 UPPER LIMB FRACTURE 8 0.0004
647 NEUROTOXICITY 7 0.0004
648 SWELLING FACE 26 0.0004
649 BRAIN INJURY 4 0.0004
650 HEART RATE IRREGULAR 9 0.0004
651 DEPRESSED MOOD 21 0.0004
652 AORTIC ANEURYSM 3 0.0004
653 SLUGGISHNESS 4 0.0004
654 MENTAL DISORDER 17 0.0004
655 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
656 LYMPHOMA 6 0.0004
657 ATRIOVENTRICULAR BLOCK 3 0.0004
658 HYPOALBUMINAEMIA 3 0.0004
659 CONTUSION 37 0.0004
660 PRODUCT DOSE OMISSION ISSUE 113 0.0004
661 ACNE 29 0.0004
662 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
663 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
664 DERMATITIS 8 0.0004
665 FOLLICULITIS 4 0.0004
666 LEUKOPENIA 19 0.0004
667 MOUTH ULCERATION 8 0.0004
668 SCRATCH 4 0.0004
669 SARS-COV-2 TEST POSITIVE 5 0.0004
670 ARTHROPATHY 21 0.0004
671 HYPERSENSITIVITY 70 0.0004
672 OFF LABEL USE 330 0.0004
673 ATRIAL FLUTTER 3 0.0004
674 JOINT INJURY 8 0.0004
675 PRESYNCOPE 9 0.0004
676 TINNITUS 17 0.0004
677 DIZZINESS 184 0.0004
678 ARTHRITIS 29 0.0004
679 UVEITIS 5 0.0004
680 PROTEINURIA 7 0.0004
681 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
682 SKIN LACERATION 4 0.0004
683 SEPSIS 41 0.0004
684 PALLOR 10 0.0004
685 GINGIVAL BLEEDING 5 0.0004
686 ABNORMAL FAECES 3 0.0004
687 HICCUPS 3 0.0004
688 ESCHERICHIA INFECTION 3 0.0004
689 GENERAL PHYSICAL HEALTH DETERIORATION 42 0.0004
690 PAIN 222 0.0004
691 VIRAL INFECTION 12 0.0004
692 THROMBOSIS 29 0.0004
693 COAGULOPATHY 6 0.0004
694 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
695 HYPERTENSIVE CRISIS 4 0.0004
696 WOUND 10 0.0004
697 MALNUTRITION 4 0.0004
698 DISEASE RECURRENCE 17 0.0004
699 CARPAL TUNNEL SYNDROME 5 0.0004
700 KIDNEY INFECTION 7 0.0004
701 SNEEZING 8 0.0004
702 HAEMORRHAGE 37 0.0004
703 SINUS DISORDER 7 0.0004
704 MITRAL VALVE INCOMPETENCE 4 0.0004
705 SEASONAL ALLERGY 5 0.0004
706 SWOLLEN TONGUE 11 0.0004
707 FACIAL PARALYSIS 3 0.0004
708 MYOCARDITIS 4 0.0003
709 HYPERSOMNIA 10 0.0003
710 MUSCULOSKELETAL DISCOMFORT 6 0.0003
711 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
712 MUSCLE STRAIN 3 0.0003
713 CYSTITIS 11 0.0003
714 NEOPLASM MALIGNANT 23 0.0003
715 HAEMATOCHEZIA 19 0.0003
716 JOINT STIFFNESS 9 0.0003
717 DEPRESSION 78 0.0003
718 MOVEMENT DISORDER 11 0.0003
719 FALL 114 0.0003
720 HEART RATE DECREASED 12 0.0003
721 METASTASES TO LIVER 6 0.0003
722 CONFUSIONAL STATE 55 0.0003
723 BACTERAEMIA 4 0.0003
724 FACIAL PAIN 3 0.0003
725 PRODUCTIVE COUGH 16 0.0003
726 ACCIDENT 4 0.0003
727 ROAD TRAFFIC ACCIDENT 14 0.0003
728 WRIST FRACTURE 4 0.0003
729 FREQUENT BOWEL MOVEMENTS 9 0.0003
730 BLOOD POTASSIUM DECREASED 10 0.0003
731 LIMB INJURY 9 0.0003
732 VISUAL IMPAIRMENT 41 0.0003
733 FUNGAL INFECTION 11 0.0003
734 BONE DISORDER 6 0.0003
735 DISCOMFORT 20 0.0003
736 HYPOAESTHESIA 49 0.0003
737 BRAIN NEOPLASM 3 0.0003
738 INCREASED TENDENCY TO BRUISE 3 0.0003
739 POOR QUALITY SLEEP 7 0.0003
740 PHARYNGEAL OEDEMA 5 0.0003
741 LUNG INFECTION 5 0.0003
742 TOOTH EXTRACTION 4 0.0003
743 APPENDICITIS 3 0.0003
744 PNEUMONIA ASPIRATION 8 0.0003
745 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
746 ABORTION INDUCED 3 0.0003
747 BLOOD SODIUM DECREASED 6 0.0003
748 MIGRAINE 30 0.0003
749 LETHARGY 18 0.0003
750 SINUSITIS 32 0.0003
751 SLEEP DISORDER 22 0.0003
752 DRY MOUTH 25 0.0003
753 RESPIRATORY TRACT INFECTION 8 0.0003
754 NERVOUSNESS 16 0.0003
755 ECZEMA 16 0.0003
756 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
757 KNEE OPERATION 3 0.0003
758 PULMONARY CONGESTION 4 0.0003
759 CHEST DISCOMFORT 31 0.0003
760 CHRONIC KIDNEY DISEASE 23 0.0003
761 C-REACTIVE PROTEIN INCREASED 11 0.0003
762 BURNING SENSATION 21 0.0003
763 MUSCULAR WEAKNESS 34 0.0003
764 EMPHYSEMA 3 0.0003
765 PAIN OF SKIN 8 0.0003
766 INSOMNIA 79 0.0003
767 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
768 CONDITION AGGRAVATED 90 0.0003
769 VERTIGO 18 0.0003
770 HEMIPARESIS 5 0.0003
771 DRUG LEVEL DECREASED 3 0.0003
772 BLOOD PRESSURE INCREASED 45 0.0003
773 CIRCULATORY COLLAPSE 5 0.0003
774 IMPAIRED GASTRIC EMPTYING 4 0.0003
775 SOMNOLENCE 59 0.0003
776 INITIAL INSOMNIA 3 0.0003
777 SCAR 5 0.0003
778 RIB FRACTURE 6 0.0003
779 CORONARY ARTERY OCCLUSION 4 0.0003
780 PERIPHERAL COLDNESS 4 0.0003
781 HYPERBILIRUBINAEMIA 3 0.0003
782 LOCALISED INFECTION 7 0.0003
783 NASAL CONGESTION 17 0.0003
784 EYE DISCHARGE 3 0.0003
785 MASS 4 0.0003
786 CATARACT 17 0.0003
787 ENCEPHALOPATHY 7 0.0003
788 INCONTINENCE 3 0.0003
789 EPISTAXIS 21 0.0003
790 STOMATITIS 17 0.0003
791 PARALYSIS 4 0.0003
792 CARDIOGENIC SHOCK 4 0.0003
793 RHINORRHOEA 18 0.0003
794 ANOSMIA 4 0.0003
795 HYPOKINESIA 4 0.0003
796 OESOPHAGITIS 3 0.0003
797 HYPERGLYCAEMIA 10 0.0003
798 JOINT SWELLING 33 0.0003
799 LOSS OF CONSCIOUSNESS 35 0.0003
800 CHILLS 32 0.0003
801 PRODUCT USE ISSUE 51 0.0003
802 DENTAL CARIES 3 0.0003
803 HAEMATOMA 7 0.0003
804 SYNCOPE 27 0.0003
805 URINARY TRACT INFECTION 46 0.0003
806 RESPIRATORY DISORDER 8 0.0003
807 OCULAR DISCOMFORT 3 0.0003
808 HEPATIC FAILURE 8 0.0003
809 BRADYCARDIA 14 0.0003
810 HAEMATURIA 9 0.0003
811 HERPES ZOSTER 15 0.0003
812 POST PROCEDURAL COMPLICATION 5 0.0003
813 LOWER LIMB FRACTURE 5 0.0003
814 ACUTE RESPIRATORY FAILURE 5 0.0003
815 GLAUCOMA 5 0.0003
816 OSTEOARTHRITIS 11 0.0003
817 ACUTE MYELOID LEUKAEMIA 4 0.0003
818 ASTHMA 29 0.0003
819 ORAL HERPES 5 0.0003
820 ADVERSE DRUG REACTION 23 0.0003
821 HYPOXIA 9 0.0003
822 INFLUENZA LIKE ILLNESS 21 0.0003
823 RESPIRATORY DISTRESS 7 0.0003
824 HOT FLUSH 19 0.0003
825 MENTAL STATUS CHANGES 7 0.0003
826 INFLAMMATION 13 0.0003
827 MACULAR DEGENERATION 3 0.0003
828 SEIZURE 29 0.0003
829 OROPHARYNGEAL PAIN 23 0.0002
830 TOXICITY TO VARIOUS AGENTS 41 0.0002
831 STAPHYLOCOCCAL INFECTION 8 0.0002
832 ILEUS 3 0.0002
833 TOOTH LOSS 5 0.0002
834 DRY EYE 12 0.0002
835 KNEE ARTHROPLASTY 5 0.0002
836 ABDOMINAL PAIN LOWER 6 0.0002
837 MUSCLE ATROPHY 3 0.0002
838 INTRAOCULAR PRESSURE INCREASED 3 0.0002
839 RECTAL HAEMORRHAGE 10 0.0002
840 HIATUS HERNIA 3 0.0002
841 CARDIAC ARREST 19 0.0002
842 NODULE 3 0.0002
843 INTENTIONAL PRODUCT USE ISSUE 20 0.0002
844 BEDRIDDEN 3 0.0002
845 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
846 EAR INFECTION 6 0.0002
847 JOINT RANGE OF MOTION DECREASED 3 0.0002
848 BALANCE DISORDER 19 0.0002
849 HYPOKALAEMIA 10 0.0002
850 HYPOMAGNESAEMIA 3 0.0002
851 COORDINATION ABNORMAL 3 0.0002
852 ERYTHEMA 44 0.0002
853 DRUG INEFFECTIVE 280 0.0002
854 INTESTINAL OBSTRUCTION 8 0.0002
855 VISUAL ACUITY REDUCED 7 0.0002
856 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
857 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
858 EAR PAIN 4 0.0002
859 DRUG DOSE OMISSION 34 0.0002
860 FIBROMYALGIA 5 0.0002
861 SKIN FISSURES 4 0.0002
862 CARDIOMYOPATHY 3 0.0002
863 TACHYCARDIA 18 0.0002
864 URINARY INCONTINENCE 6 0.0002
865 RENAL INJURY 6 0.0002
866 LYMPHADENOPATHY 7 0.0002
867 SKIN IRRITATION 9 0.0002
868 EPILEPSY 6 0.0002
869 FEELING HOT 12 0.0002
870 HYPONATRAEMIA 11 0.0002
871 ERECTILE DYSFUNCTION 5 0.0002
872 EMOTIONAL DISORDER 6 0.0002
873 FEMUR FRACTURE 6 0.0002
874 ANXIETY 55 0.0002
875 OCULAR HYPERAEMIA 9 0.0002
876 HYPOTENSION 38 0.0002
877 PNEUMOTHORAX 3 0.0002
878 SKIN CANCER 4 0.0002
879 BLOOD GLUCOSE INCREASED 35 0.0002
880 ADVERSE EVENT 17 0.0002
881 SEPTIC SHOCK 8 0.0002
882 METASTASES TO BONE 3 0.0002
883 TREATMENT NONCOMPLIANCE 10 0.0002
884 OSTEONECROSIS 6 0.0002
885 HEART RATE INCREASED 18 0.0002
886 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
887 EXPIRED PRODUCT ADMINISTERED 6 0.0002
888 GLOSSODYNIA 4 0.0002
889 HYPERHIDROSIS 23 0.0002
890 PRODUCT USE IN UNAPPROVED INDICATION 44 0.0002
891 PAIN IN JAW 5 0.0002
892 VISION BLURRED 24 0.0002
893 LOCAL SWELLING 3 0.0002
894 NEUTROPHIL COUNT DECREASED 7 0.0002
895 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
896 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
897 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
898 DEEP VEIN THROMBOSIS 11 0.0002
899 BLOOD GLUCOSE DECREASED 8 0.0002
900 PANIC ATTACK 6 0.0002
901 TREMOR 27 0.0002
902 BLOOD GLUCOSE ABNORMAL 3 0.0002
903 AGRANULOCYTOSIS 3 0.0002
904 HEPATIC STEATOSIS 3 0.0002
905 NERVOUS SYSTEM DISORDER 5 0.0002
906 MUSCULOSKELETAL STIFFNESS 14 0.0002
907 PHOTOPHOBIA 3 0.0002
908 FRACTURE 3 0.0002
909 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
910 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
911 THROAT IRRITATION 7 0.0002
912 DIPLOPIA 4 0.0002
913 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
914 SURGERY 9 0.0002
915 CYTOKINE RELEASE SYNDROME 3 0.0001
916 ANGER 5 0.0001
917 RENAL CANCER 7 0.0001
918 PARAESTHESIA 23 0.0001
919 RESPIRATORY ARREST 4 0.0001
920 HYPOGLYCAEMIA 7 0.0001
921 DELIRIUM 5 0.0001
922 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
923 IMPAIRED WORK ABILITY 3 0.0001
924 SKIN BURNING SENSATION 10 0.0001
925 BREAST CANCER 13 0.0001
926 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
927 RESTLESSNESS 5 0.0001
928 FEBRILE NEUTROPENIA 9 0.0001
929 BLOOD PRESSURE DECREASED 9 0.0001
930 DYSARTHRIA 5 0.0001
931 MUSCLE TWITCHING 3 0.0001
932 DISTURBANCE IN ATTENTION 7 0.0001
933 BLOOD CHOLESTEROL INCREASED 6 0.0001
934 PSORIATIC ARTHROPATHY 5 0.0001
935 IMPAIRED HEALING 4 0.0001
936 LUNG NEOPLASM MALIGNANT 5 0.0001
937 OSTEONECROSIS OF JAW 3 0.0001
938 RHABDOMYOLYSIS 5 0.0001
939 URINARY RETENTION 4 0.0001
940 CARDIO-RESPIRATORY ARREST 5 0.0001
941 BLADDER CANCER 7 0.0001
942 TYPE 2 DIABETES MELLITUS 4 0.0001
943 GASTRIC CANCER 3 0.0001
944 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
945 MUCOSAL INFLAMMATION 3 0.0001
946 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 23 0.0001
947 PROSTATE CANCER 9 0.0001
948 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
949 ACCIDENTAL OVERDOSE 4 0.0001
950 AGITATION 8 0.0001
951 ABNORMAL DREAMS 3 0.0001
952 EYE PAIN 6 0.0001
953 NO ADVERSE EVENT 19 0.0001
954 MULTIPLE SCLEROSIS 5 0.0001
955 PANCREATIC CARCINOMA 3 0.0001
956 DISORIENTATION 4 0.0001
957 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
958 LACRIMATION INCREASED 3 0.0001
959 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
960 OSTEOPOROSIS 4 0.0001
961 GYNAECOMASTIA 3 0.0001
962 BONE DENSITY DECREASED 3 0.0001
963 PULMONARY EMBOLISM 9 0.0001
964 METABOLIC ACIDOSIS 3 0.0001
965 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
966 EYE PRURITUS 3 0.0001
967 ILL-DEFINED DISORDER 5 0.0001
968 HALLUCINATION 6 0.0001
969 SUICIDAL IDEATION 7 0.0001
970 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
971 ABORTION SPONTANEOUS 3 0.0001
972 ANAPHYLACTIC REACTION 4 0.0001
973 INJURY 5 0.0001
974 WHEEZING 4 0.0001
975 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
976 COMA 3 0.0001
977 PRODUCT QUALITY ISSUE 8 0.0001
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
979 MOBILITY DECREASED 4 0.0001
980 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
981 MEDICATION ERROR 3 0.0001
982 UNEVALUABLE EVENT 4 0.0001
983 RHEUMATOID ARTHRITIS 6 0.0001
984 INCORRECT DOSE ADMINISTERED 12 0.0001
985 FLUSHING 5 0.0000
986 PRODUCT STORAGE ERROR 4 0.0000
987 OVERDOSE 8 0.0000
988 EMOTIONAL DISTRESS 4 0.0000
989 INJECTION SITE ERYTHEMA 3 0.0000
990 DRUG DEPENDENCE 3 0.0000